XYLONEURAL sol inj s cons 50 amp 5 ml

7680427730266 CH-42773 N01BB02 01.02.2.
XYLONEURAL sol inj s cons 50 amp 5 ml
XYLONEURAL sol inj s cons 50 amp 5 ml
XYLONEURAL sol inj s cons 50 amp 5 ml
1 / 3
google

Details

Product number
4277301
CPT
-
Packaging group
50 x 5 mL
Unit
Ampulle(n)
Composition
lidocaini hydrochloridum anhydricum 10 mg ut lidocaini hydrochloridum monohydricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabilia, q.s. ad solutionem pro 1 ml corresp. natrium 3.56 mg.

Articles (1)

Xyloneural, Injektionslösung
Injektionslösung
50 x 5 mL
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
17/11/2021
Professional SmPC
Français
17/11/2021
Professional SmPC
Italien
17/11/2021

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.56 MG Substance HBESI

Authorization holder

Gebro Pharma AG

4410 Liestal

Authorization information

Swissmedic authorization number
42773
Drug name
Xyloneural, Injektionslösung
Galenic form
LSINJ
ATC Code
N01BB02
Authorization status
Revoked/Withdrawn
Dispensation category
B
First authorization
15/01/1981
Authorization expiration date
31/07/2025
IT number
01.02.2.
Domain
Human medicine
Field of application
Neuraltherapie

Packaging details

Description (FR)
XYLONEURAL sol inj s cons 50 amp 5 ml
Description (DE)
XYLONEURAL Inj Lös o Kons 50 Amp 5 ml
Market launch
15/01/1981
Market withdrawal
31/07/2025
Narcotic (BTM)
No

Other packaging sizes

XYLONEURAL sol inj s cons 5 amp 5 ml
5 x 5 mL AMP
View